Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
We are looking for a student who is currently studying in or near Graz and is keen to put their theoretical knowledge into practice by supporting our automotive NFC Customer Application engineering team. This part-time position